Theriva Biologics Inc. (NYSE AMERICAN: TOVX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT THERIVA BIOLOGICS INC.

Theriva Biologics Inc. (NYSE AMERICAN: TOVX)
Listen to this Section


$0.28
-0.0100 ( -3.50% ) 387.7K

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Market Data


Open $0.28
Previous Close $0.29
Volume 387.7K
Market Cap $13.13M
Day Range $0.27 - $0.29
52 Week Range $0.16 - $0.86
Shares Outstanding 45.89M
Change % -3.50%
Net Change ▼ -0.0100
Insider Ownership N/A
Exchange NYSE AMERICAN
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year1993
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -1,030,000.00

Date Type Amount Purchased Purchaser
2023-12-15 Sale -110000.00 MONAHAN JOHN J
2023-12-15 Sale -110000.00 Kraws Jeffrey J
2023-12-15 Sale -110000.00 Wolf Jeffrey Alan
2023-12-15 Sale -700000.00 SHALLCROSS STEVEN A

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 74 Nov 12, 2025
8-k 8K-related 14 Nov 12, 2025
def Proxies and info statements 4 Nov 10, 2025
pre Proxies and info statements 4 Oct 31, 2025
8-k 8K-related 14 Oct 29, 2025
8-k 8K-related 14 Oct 24, 2025
8-k 8K-related 28 Oct 20, 2025
8-k 8K-related 15 Oct 17, 2025
8-k 8K-related 15 Oct 14, 2025
8-k 8K-related 46 Oct 08, 2025

Latest News


× Before browsing our site, please accept our cookies policy